Abstract:Background: ZPI-protein Z complex is a critical anticoagulant regulator of membrane-associated factor Xa. Results: The energetics and multistep kinetics of the ZPI-protein Z interaction were characterized with fluorescently labeled K239C ZPI. Conclusion: Ionic and hydrophobic interactions mediate ZPI-protein Z binding, and conserved ZPI Lys-239 promotes protein Z dissociation. Significance: The studies establish the thermodynamic and kinetic basis for catalytic activation of ZPI by protein Z. The anticoagulant serpin, protein Z-dependent protease inhibitor (ZPI), circulates in blood as a tight complex with its cofactor, protein Z (PZ), enabling it to function as a rapid inhibitor of membrane-associated factor Xa. Here, we show that N,N′-dimethyl-N-(acetyl)-N′-(7-nitrobenz-3-oxa-1,3-diazol-4-yl)ethylenediamine (NBD)-fluorophore-labeled K239C ZPI is a sensitive, moderately perturbing reporter of the ZPI-PZ interaction and utilize the labeled ZPI to characterize in-depth the thermodynamics and kinetics of wild-type and variant ZPI-PZ interactions. NBD-labeled K239C ZPI bound PZ with ∼3 nm KD and ∼400% fluorescence enhancement at physiologic pH and ionic strength. The NBD-ZPI-PZ interaction was markedly sensitive to ionic strength and pH but minimally affected by temperature, consistent with the importance of charged interactions. NBD-ZPI-PZ affinity was reduced ∼5-fold by physiologic calcium levels to resemble NBD-ZPI affinity for γ-carboxyglutamic acid/EGF1-domainless PZ. Competitive binding studies with ZPI variants revealed that in addition to previously identified Asp-293 and Tyr-240 hot spot residues, Met-71, Asp-74, and Asp-238 made significant contributions to PZ binding, whereas Lys-239 antagonized binding. Rapid kinetic studies indicated a multistep binding mechanism with diffusion-limited association and slow complex dissociation. ZPI complexation with factor Xa or cleavage decreased ZPI-PZ affinity 2–7-fold by increasing the rate of PZ dissociation. A catalytic role for PZ was supported by the correlation between a decreased rate of PZ dissociation from the K239A ZPI-PZ complex and an impaired ability of PZ to catalyze the K239A ZPI-factor Xa reaction. Together, these results reveal the energetic basis of the ZPI-PZ interaction and suggest an important role for ZPI Lys-239 in PZ catalytic action.

Characterization of the Heparin-Binding Site of the Protein Z-Dependent Protease Inhibitor

Heparin Activation of Protein Z-dependent Protease Inhibitor (ZPI) Allosterically Blocks Protein Z Activation Through an Extended Heparin-Binding Site.

Kinetic Characterization of the Protein Z-Dependent Protease Inhibitor Reaction with Blood Coagulation Factor Xa

Structural Basis for Catalytic Activation of Protein Z-dependent Protease Inhibitor (ZPI) by Protein Z.

Crystal Structure of Protein Z-Dependent Inhibitor Complex Shows How Protein Z Functions As A Cofactor in the Membrane Inhibition of Factor X

Thermodynamic and Kinetic Characterization of the Protein Z-dependent Protease Inhibitor (Zpi)-Protein Z Interaction Reveals an Unexpected Role for ZPI Lys-239

Mechanism of Protein-Z-Mediated Inhibition of Coagulation Factor Xa by Z-Protein-Dependent Inhibitor: A Molecular Dynamic Approach

Structural Determinants For Heparin Binding In Human Coagulation Factor Xi

Protein Z-dependent Protease Inhibitor/protein Z Complex, a New Target for Hemophilia Treatment

An Inhibitory Single-Domain Antibody against Protein Z-Dependent Protease Inhibitor Promotes Thrombin Generation in Severe Hemophilia A and FXI Deficiency

Characterization of A Small Molecule Pai-1 Inhibitor, Zk4044

Structure-based engineering of heparinase I with improved specific activity for degrading heparin

Expression and Characterization of Kunitz Domain 3 and C-terminal of Human Tissue Factor Pathway Inhibitor-2.

Helix D Elongation and Allosteric Activation of Antithrombin

The role of the protein Z and protein Z-dependent protease inhibitor in thrombotic diseases

Modulation of Serpin Reaction Through Stabilization of Transient Intermediate by Ligands Bound to Α-Helix F

Functional interaction of plasminogen activator inhibitor type 1 (PAI-1) and heparin

High-throughput amino acid-level characterization of the interactions of plasminogen activator inhibitor-1 with variably divergent proteases

P1 and P2' site mutations convert protease nexin-2 from a factor XIa inhibitor to a plasmin inhibitor.

Catalytic Mechanism of Heparinase II Investigated by Site-directed Mutagenesis and the Crystal Structure with Its Substrate*

A common protein C inhibitor exosite partially controls the heparin induced activation and inhibition of serine proteases